PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Luteinization”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 973 records · Page 54Linked to original sources

Injection of bicuculline elicits firing of luteinizing hormone releasing hormone pulse generator in muscimol-treated ovariectomized rats.

We have already demonstrated that, although exogenous gamma-aminobutyric acidA (GABAA) receptor agonist is capable of inhibiting the activity of luteinizing hormone releasing hormone (LHRH) pulse generator, the reduction in the endogenous GABAA receptor activity does not have a significant effect in ovariectomized rats, suggesting a minor role of inhibitory GABA neurons in the control of pulsatile release of LHRH. In this study, we further analyzed the role of the GABAA receptor system in the regulation of LHRH pulse generator activity observed by recording the multiunit activity (MUA) in the hypothalamus of ovariectomized rats. An abrupt increase (volley) in the MUA in the arcuate nucleus (ARC)-median eminence region (ME) was accompanied by the initiation of a luteinizing hormone (LH) pulse, determined by measuring LH concentrations in blood sampled simultaneously. The injection of 1-3 mg/kg muscimol (MUS), a GABAA receptor agonist, decreased the basal MUA and delayed the occurrence of the next MUA volley, but it did not change the LH pulse amplitude. I.v. injection of 5 mg/kg bicuculline (BIC), a GABAA receptor antagonist, during continuous infusion of MUS (5 mg/kg/h) which decreased the basal MUA and prevented the MUA volley from occurring, evoked MUA volleys and LH pulses whose amplitudes were similar to those found before the MUS infusion. Injection of the same dose of BIC during the infusion of saline increased the MUA transiently, but this increase was not accompanied by an LH pulse and afterwards there occurred MUA volleys at ordinary intervals accompanied by LH pulses with unchanged pulse amplitudes.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Serum levels of luteinizing hormone (LH), prolactin, estradiol, and progesterone in laying and nonlaying canvasback ducks (Aythya valisineria).

Temporal changes in the levels of serum luteinizing hormone (LH), prolactin, estradiol, and progesterone associated with the reproductive patterns of 53 wild captive canvasback ducks were measured. The reproductive endocrinology of both laying and nonlaying females was compared in this 3-year study. Females that remained sexually inactive had ovaries with small, undeveloped follicles. Nonlaying ducks also had lower serum levels of LH (P less than 0.01), prolactin (P less than 0.05), estradiol, and progesterone than those of laying ducks in mid-April (during prelay), mid-May (on the fourth day of egg production), and mid-June (during postlay and incubation). Prolactin levels of both layers and nonlayers increased over this time interval (P less than 0.01) but levels of nonlayers were significantly lower than those of layers for the three blood-sampling dates. The low prolactin levels demonstrate that reproductive failure was not a result of inhibition by high serum prolactin levels. Intravenous injections of luteinizing hormone-releasing hormone (LHRH) in female canvasbacks resulted in significantly elevated (P less than 0.01) serum LH on the prelay blood sampling date. Lack of reproduction in nonbreeding canvasbacks was thus associated with low circulating serum LH levels but with LHRH-sensitive pituitary pools. These data suggest that lack of reproduction was a result of the failure of the hypothalamus to release releasing factors. The serum hormones of laying canvasbacks varied temporally with stages of the nesting cycle. LH levels increased prior to egg laying and fluctuated during the laying period. LH levels decreased at the onset of incubation but increased after loss of clutch, with renesting activity. Serum prolactin levels of layers were low prior to egg laying and increased gradually through laying of the first clutch, the renesting period, and laying of the second clutch. The highest prolactin levels occurred in ducks incubating their eggs. Prolactin levels decreased in ducks that failed to incubate their eggs. Serum estradiol levels increased sharply between 2 and 5 weeks prior to egg laying and remained high until the second day of egg production. Estradiol levels decreased when the fourth egg was produced, and remained low through the laying of the first clutch, the renesting period, and laying of the second clutch. Progesterone fluctuated widely through the nesting cycle, showing several major peaks before laying and another during incubation.

Animals↗

Hypothalamic and serum factors influence on prolactin and luteinizing hormone release by the pituitary gland of the young turkey (Meleagris gallopavo).

Intravenous administration of 1.0 or 3.0 eq hypothalamic extract (HE) to 8-week-old male and 7-week-old female turkeys, respectively, induced an increase in circulating prolactin (PRL) levels but had no effect on circulating luteinizing hormone (LH) levels. The incubation of dissociated anterior pituitary cells from 13-week-old female turkeys with HE induced a dose-related increase in PRL release; however, only the highest dose of HE induced an increase in LH release. Coincubation of a hypothalamic fragment with anterior pituitary cells from 9-week-old females induced a release of both PRL and LH. Dissociated pituitary cells from 11-week-old females initially incubated for 3 hr in medium containing charcoal-treated (stripped) turkey serum yielded a larger release of PRL and LH in the presence of HE than did cells initially incubated with turkey serum or no serum. Luteinizing hormone-releasing hormone (LHRH) induction of LH release was greatest from cells initially incubated with stripped serum for 3 or 24 hr. The LHRH-induced LH release was completely blocked in cells initially incubated for 24 hr with turkey serum. The initial incubation of cells for 24 hr with stripped serum yielded a larger release of PRL and LH in response to HE than did cells initially incubated with serum. The hypothalamus of the young turkey contains substantial PRL-releasing activity as well as LH-releasing activity. The ability of the releasing factors to stimulate pituitary hormone release is influenced by factors present in the blood of the young turkey. This is especially evident in the LHRH-induced LH release where serum factors inhibited the release.

Animals↗

Effects of chicken (Gln8)- and mammalian (Arg8)-luteinizing hormone-releasing hormones on the release of gonadotrophins in vitro and in vivo from the adenohypophysis of Japanese quail.

Both chicken luteinizing hormone-releasing hormone (Gln8-LH-RH) and mammalian luteinizing hormone-releasing hormone (Arg8-LH-RH) increased the release of FSH and LH from adenohypophysial halves of adult male Japanese quail when the halves were incubated in a medium containing LH-RH. Elevation of the FSH release was less marked than that of the LH release irrespective of the LH-RH species. A pulse stimulation (10 min) of adenohypophysial halves with chicken as well as mammalian LH-RH in vitro resulted in a burst of both FSH and LH release. The increment of the FSH release was smaller than that of the LH release. A single intravenous injection of each LH-RH to adult male quail induced rapid increases of plasma FSH and LH levels within 5 min. The plasma levels of FSH and LH returned to their initial levels at varying times after the injection depending on the dose of LH-RH. Again, the increment of the FSH level was smaller than that of the LH level, showing a similar profile to the in vitro pulse stimulation experiment. No significant difference in ability to stimulate FSH and LH secretions from the quail adenohypophysis was detected between chicken and mammalian LH-RHs under either in vivo or in vitro conditions, whereas chicken LH-RH has been reported to be far less potent than mammalian LH-RH when tested on the rat adenohypophysis.

Animals↗

Effects of two kinds of chicken luteinizing hormone-releasing hormone (LH-RH), mammalian LH-RH and its analogs on the release of LH and FSH in Japanese quail and chicken.

A newly isolated and characterized chicken luteinizing hormone-releasing hormone-II (chicken LH-RH-II, Miyamoto et al., 1984) had luteinizing hormone (LH) and follicle-stimulating hormone (FSH) releasing activity in vitro and in vivo in Japanese quail: the activity was almost equal to chicken LH-RH-I and mammalian LH-RH. These three LH-RHs induced the release of LH several times higher than that of FSH in vitro and also in vivo. No significant difference between chicken LH-RH-I and LH-RH-II was observed in LH releasing activity in vitro using chicken pituitary gland in the same incubating condition as in quail. Another experiment indicated that no synergism existed between chicken LH-RH-I and -II and that there was neither LH nor FSH releasing activity in [D-Phe2, Pro3, D-Phe6]-LH-RH or in mesotocin. However, the same potency as in the chicken LH-RH-II was observed in [D-Ala6, des-Gly10]-LH-RH ethylamide, a superactive analog in mammals. The results indicate that an avian adenohypophysis differs from a mammalian adenohypophysis in its responsiveness to LH-RH suggesting that an avian LH-RH receptor may have a lower specificity in "recognition" of LH-RH molecules than a mammalian LH-RH receptor has.

Animals↗

Gonadal steroid-mediated alteration of luteinizing hormone secretion by anterior pituitary cells of young turkeys.

The magnitude of luteinizing hormone (LH) release during a 3-hr test incubation was diminished (P less than 0.05) when anterior pituitary cells from young turkeys were cultured for 24 to 120 hr. This trend was evident with basal LH release and with LH release induced by luteinizing hormone-releasing hormone (LH-RH) or hypothalamic extract. Anterior pituitary cells were cultured with various concentrations (10(-14) to 10(-6) M) of estradiol (E2), progesterone (P4), or testosterone (T) for 24 hr and then exposed to LH-RH or control medium for 3 hr, still in the presence of steroids. Basal LH release was potentiated (P less than 0.05) when cells were cultured with 10(-8) or 10(-6) M T, but not with E2 or P4. When cells were cultured with E2, LH release in the presence of 10(-8) M LH-RH was enhanced (P less than 0.05) in a dose-dependent fashion. LH-RH mediated LH release was also enhanced (P less than 0.05) when cells were cultured with 10(-8) M P4 or 10(-6) M T. Gonadal steroids can act directly on the anterior pituitary of the young domestic turkey to modulate LH release, with T enhancing basal LH release and E2 potentiating LH-RH-mediated LH release.

Animals↗

Steroids modulate the release of luteinizing hormone from quail pituitary cells.

An enzymatically dispersed pituitary preparation from male Japanese quail (Coturnix coturnix) was used to study the effects of gonadal and adrenal steroids on gonadotropin release. Cells were preincubated for 18 hr with or without steroids and then challenged with chicken luteinizing hormone-releasing hormone (cLH-RH I; Gln8-LH-RH). Preincubation with testosterone (T; 10 nM) significantly suppressed (P less than 0.05) luteinizing hormone release in response to cLH-RH I (10 ng/ml). Preincubation with 5 alpha-dihydrotestosterone (5 alpha-DHT) (10 nM) caused even further suppression of LH-RH-stimulated LH release while the same concentration of 5 beta-dihydrotestosterone and estradiol-17 beta had no effect. In addition, preincubation with corticosterone (10 nM) significantly (P less than 0.01) suppressed the amount of LH released in response to cLH-RH I. Pituitary cells from immature males, when stimulated with cLH-RH I, released LH in a dose-related manner. Neither T nor 5 alpha-DHT (10 nM) altered the effect of LH-RH. These data suggest that T and 5 alpha-DHT play a role in mediating LH release in the avian pituitary while 5 beta-reduced androgens have no effect. There appears to be no androgen effect in the immature quail. In addition, corticosterone seems to be a factor in controlling gonadotropin secretion in the quail.

Animals↗

Comparison of in vivo biological activities of luteinizing hormone releasing hormone (LHRH) analogues in 60-day-old cockerels.

The in vivo biological activities of various luteinizing hormone releasing hormone (LHRH) analogues in immature 60-day-old cockerels were compared, based on their capacity to increase circulating luteinizing hormone (LH) concentrations. Intravenous injections of 50, 100, or 500 ng of [Gln8]LHRH (cGnRH-I) and [His5,Trp7,Tyr8]LHRH(cGnRH-II) induced significant increases in the plasma LH level. The maximum response was always observed 2 min after the injection. Mammalian LHRH(mGnRH) significantly increased plasma LH, but only at the 500 ng dosage level. [Ile8]LHRH, [D-Ala6]LHRH, [Ala4]LHRH, [Leu8]LHRH, and [Phe5]LHRH increased plasma LH at 50-500 ng. [Ile7]LHRH, [Phe3]LHRH, and [Phe2]LHRH did not significantly increase plasma LH. Relative in vivo biological activities, calculated from dose (30-100 ng)-response curves of mGnRH-I, cGnRH-I, cGnRH-II, [Ile8]LHRH, [D-Ala6]LHRH, [Ala4]LHRH, [Leu8]LHRH, [Ile5]LHRH, [Ile7]LHRH, [Phe3]LHRH, and [Phe2]LHRH were 1.00, 1.40, 1.81, 1.50, 4.59, 1.90, 1.28, 1.56, 0.57, 0.67, and 0.57, respectively. These results demonstrate that avian LHRHs have higher biological activities than mammalian LHRH in the chicken. Furthermore, cGnRH-II is more potent than cGnRH-I, and [D-Ala6]LHRH has a very high activity while [Ile7]LHRH and [Phe2]LHRH have very low activities.

Animals↗

Impaired steroidogenesis in the luteal phase of the reproductive cycle and during pregnancy in rhesus monkeys immunized with the beta-subunit of ovine luteinizing hormone.

Monkeys immunized with the beta-subunit of ovine luteinizing hormone (oLH beta) develop antibodies which cross react with rhesus chorionic gonadotropin (rhCG) and luteinizing hormone (rhLH). Immunization causes shortened menstrual cycles and reduced fertility. Fertility can be restored by administration of medroxyprogesterone acetate (MPA) during the first 5 weeks of pregnancy. In the present study, we have measured the effects of circulating oLH beta-antibodies on peripheral estradiol, progesterone and 17 alpha OH-progesterone (17OH-P) concentrations throughout the menstrual cycle and during gestation in monkeys which became pregnant following MPA-treatment. Progesterone concentrations were markedly reduced during the luteal phase in cycling animals and the luteal phase of the cycle was significantly shorter as compared to non-immunized controls. Concentrations of estradiol and 17OH-P in the peripheral circulation were not affected by the oLH beta-antibodies. In immunized monkeys which became pregnant following MPA-treatment, progesterone and 17OH-P levels were consistently lower and estradiol concentrations were increased during the second and third trimesters. Our results show that circulating antibodies to oLH beta have multiple endocrinological effects. Corpus luteum function is impaired in cycling monkeys and during the early part of pregnancy. In addition, the pattern of steroid secretion remains abnormal in pregnant monkeys even after the luteal-placental shift.

Animals↗

The role of lipoproteins in steroidogenesis by human luteinized granulosa cells in culture.

Progesterone secretion by primary cultures of luteinized human granulosa cells was markedly reduced when the cells were incubated in lipoprotein-deficient medium. Addition of LDL, but not HDL3, to cells cultured in lipoprotein-deficient medium stimulated progestin secretion. The effects of LDL were dose-dependent and saturable (Km = 5.5 micrograms LDL protein/ml). LDL also stimulated [3H]-oleate incorporation into cellular sterol esters, with half maximal stimulation occurring at LDL concentrations of 10 micrograms protein/ml. The cultured cells bound and internalized [125I]-LDL in a dose dependent and saturable manner (Km = 5-10 micrograms LDL protein/ml). [125I]-LDL uptake was specific in that unlabeled LDL, but not unlabeled HDL3, competed with labeled LDL for uptake [125I]-HDL3 was also taken up by the cells, but by a lower affinity mechanism. We conclude that luteinized human granulosa cells utilize LDL-carried cholesterol for progestin synthesis, and that LDL is taken up via a specific, high affinity process.

Biological Transport↗

Exposure to alcohol in utero alters the adult patterns of luteinizing hormone secretion in male and female rats.

Luteinizing hormone (LH) secretory patterns were characterized in adult male and female rats exposed to ethanol during the last week of fetal life. Gonadectomized fetal alcohol exposed (FAE) males and females had significantly reduced plasma LH titers as compared to those of pair-fed (PF) controls. The phasic afternoon LH secretory response to estrogen and progesterone priming was also significantly reduced in FAE females. These differences do not appear to be a result of altered pituitary sensitivity to luteinizing hormone releasing hormone (LHRH), since the infusion of LHRH resulted in an equal response in PF and FAE females. Subsequent characterization of the episodic pattern of LH secretion in FAE males revealed significantly reduced mean LH level as well as a decreased pulse amplitude and frequency when compared to PF males. Taken together, these data indicate that some of the central mechanisms controlling pituitary LH secretion are altered by prenatal exposure to alcohol.

Animals↗

Luteinizing hormone releasing activity of [Gln8]-LHRH and [His5, Trp7, Tyr8]-LHRH in the cockerel, in vivo and in vitro.

The luteinizing hormone (LH)-releasing activity of two distinct chicken luteinizing hormone releasing hormones ([Gln8]-LHRH and [His5, Trp7, Tyr8]-LHRH) were evaluated in white Leghorn cockerels. In the first study, thirty birds were randomly allotted to five groups and injected, i.v., with 0.9% saline, [Gln8]-LHRH (cLHRH I, 1 microM or 10 microM) or [His5, Trp7, Tyr8]-LHRH, (cLHRH II; 1 microM or 10 microM). Blood samples were drawn prior to and through 60 min following the injection, and plasma was collected for LH determination. In the second study, anterior pituitary cells from cockerels were dispersed and preincubated for 1 hr. Approximately 1.5 X 10(5) cells per tube were incubated with either Medium 199 buffer (control), 8-bromo-cAMP or various doses of cLHRH I or cLHRH II at final concentrations ranging from 0.02 to 100.0 nM. At the end of a two hour incubation, supernatant was collected and the concentration of LH determined. Injection of cLHRH I or cLHRH II at 1 microM and 10 microM levels caused a significant increase in blood LH concentrations which peaked 5 min following injection. There were, however, no differences between the stimulatory effect of cLHRH I compared to cLHRH II at either dose. On the other hand, cLHRH II was found to be 4.7 times more potent than cLHRH I in stimulating LH release from dispersed pituitary cells. It is suggested that cLHRH II may have greater affinity for the gonadotroph receptor, greater uptake by the cell, and/or that it may be more resistant to in vitro degradation than cLHRH I. On the other hand, an extra pituitary site of degradation may be more effective in metabolizing cLHRH II, resulting in its equipotency with cLHRH I, in vivo.

Animals↗

Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.

Although a central site of acute opiate action in regulating luteinizing hormone (LH) secretion has been suggested by the ability of centrally implanted opiate antagonists to increase LH levels, opiate antagonists are lipophilic and could influence the pituitary in situ. Also, the physiological significance of opiate receptor blockade with antagonists rests on the assumed, but untested, stereoselectivity of these receptors. Therefore, a lipophobic quaternized derivative of naltrexone (MRZ 2663-Naltrexone methobromide) and dextro- (+) and levo- (-) stereoisomers of naloxone were used to study the site- and stereoselectivity of gonadotropin responses to opiate antagonists in vivo. Male rats were injected intracerebroventricularly (icv) or intravenously (iv) with the quaternary or tertiary congeners of naltrexone and subcutaneously (sc) with (-) or (+)-naloxone. Rats injected icv with 20 ug of quaternary naltrexone displayed significant increases in serum luteinizing hormone (LH). The onset of the response was rapid with serum LH levels being significantly elevated 15 minutes after the injection and returning to basal levels 30 minutes later. Rats injected iv with 10 mg/kg of quaternary naltrexone failed to show significant LH responses. Rats injected either centrally or periphally with equivalent doses of tertiary naltrexone showed LH responses that were similar to those found in animals injected icv with quaternary naltrexone. As little as 0.5 mg/kg of (-)-naloxone resulted in significant elevations in serum LH that were higher than those elicited by up to 10 mg/kg of (+)-naloxone, indicating that this effect of naloxone is stereoselective. These data support the argument that opioids can acutely modulate LH secretion through actions at stereoselective opioid receptors in the central nervous system.

Animals↗

Pituitary-gonadal function in chronic renal failure: the effect of luteinizing hormone--releasing hormone and the influence of dialysis.

Sixteen adult male patients with chronic renal failure undergoing either chronic intermittent hemodialysis (HD) or chronic intermittent peritoneal dialysis (PD) were studied both before and immediately after dialysis. The gonadotropin responses to luteinizing hormone-releasing hormone (LH-RH) was determined, revealing an excessive luteinizing hormone (LH) response with a delayed return to normal in both dialysis groups. No significant alteration in follicle-stimulating hormone (FSH) kinetics was observed. There was no significant difference in the mean gonadotropin responses to LH-RH between the HD and PD groups, and dialysis had no effect on either mean LH or FSH responses. The chronic renal failure patients with testicular atrophy had an excessive FSH response to LH-RH when compared to those patients without testosterone was significantly lower than normal. Chronic renal failure effects testicular function and testicular atrophy is associated with seminiferous tubular destruction and an excessive FSH response. Poor renal clearance may play a role in the abnormal LH response observed.

Adult↗

Mechanism of action of luteinizing hormone and follicle-stimulating hormone on the ovary in vitro.

The mechanism of action of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) upon various cell types of the mammalian ovary is reviewed. Emphasis is placed upon in vitro studies using organ and cell culture as well as short-term incubations. FSH and LH actions upon the following ovarian functions are discussed: steroidogenesis and metabolism of the ovary as a whole and of the isolated follicle and its component cell types, the granulosa and thecal cells, as well as folliculogenesis and follicular growth, oocyte maturation, follicular rupture, and corpus luteum maintenance and steroidogenesis. The roles of gonadotropin receptors, AMP, prostaglandins, protein kinase, and protein synthesis in these LH and FSH actions are discussed. Intra-ovarian regulation of LH and FSH action is reviewed, including a discussion of the possible roles of follicular fluid inhibitors upon oocyte maturation and granulosa cell luteinization.

Animals↗

Hyperactivity aggravates semistarvation-induced changes in corticosterone and triiodothyronine concentrations in plasma but not luteinizing hormone and testosterone levels.

Semistarvation over a ten-day period resulted in a weight loss of 30% in male Wistar rats, which had continuous access to a running wheel. The animals increased their activity up to 20 km per day. Controls fed ad lib increased activity only slightly (up to 2.3 km on day ten). Groups of semistarved and ad lib-fed sedentary rats were studied as controls. The circadian pattern of corticosterone (B), triiodothyronine (T3), luteinizing hormone (LH) and testosterone (T) was studied. Corticosterone was synergistically increased by semistarvation and exercise. The reduction of triiodothyronine by semistarvation was significantly greater in the running wheel group. Both luteinizing hormone and testosterone were significantly decreased by semistarvation. Hyperactivity did not result in additional suppression of LH and testosterone.

Animals↗

Delay in the age of balano-preputial skinfold cleavage and alterations in serum profiles of testosterone, 5 alpha-androstane-3 alpha,17 beta-diol, and gonadotropins in adult rats treated during puberty with luteinizing hormone releasing hormone.

Previous work has shown that chronic treatment of intact, immature male rats with luteinizing hormone releasing hormone (LHRH) decreases sex accessory gland weights and results in retardation of the normal developmental increase in the ratio of serum testosterone (T)/5 alpha-androstane-3 alpha,17 beta-diol (3 alpha-Diol) via an apparent enhancement of testicular 5 alpha-reductase or 3 alpha-hydroxysteroid oxidoreductase activities. In the present work, androgen dependent balano-preputial skinfold cleavage was significantly delayed by approximately one week in intact, immature male rats which were treated daily for two weeks with either 1.0 micrograms, 2.5 micrograms or 5.0 micrograms of LHRH during a discrete phase of pubertal development (28-41 days of age). In intact, adult (62 day old) animals which received LHRH treatments during pubertal development, serum T concentrations and sex accessory gland weights were reduced compared to control animal values. Serum 3 alpha-Diol content in the adult rats was either unaltered or increased significantly depending on the LHRH dosage employed during sexual development. Serum luteinizing hormone concentrations were not different between control and LHRH-pretreated adult rats whereas the highest dosage of LHRH employed (5.0 micrograms) during puberty resulted in a significant elevation of adult serum follicle stimulating hormone levels. It is suggested that chronic LHRH treatment of the male rat during puberty results in a perturbation in testicular androgen biosynthetic activities and an impairment of pituitary-testicular hormone feedback mechanisms which persist at least through early adulthood.

Androstane-3,17-diol↗

Action of luteinizing hormone-releasing hormone and synthesis of prostaglandin in the pituitary gland.

The possibility that prostaglandin E2 (PGE2) may play a role in luteinizing hormone (LH) release was examined using an in vitro model. Addition of luteinizing hormone-releasing hormone (LH-RH) to the culture medium stimulated cyclic AMP accumulation and LH-release by incubated hemipituitaries, but did not affect the level of PGE2 or prostaglandin synthetase activity in the gland. Aspirin and indomethacin reduced both prostaglandin synthetase activity and PGE2 or prostaglandin synthetase activity in the gland. Aspirin and indomethacin reduced both prostaglandin synthetase activity and PGE2 content in the pituitary, but did not impair the stimulatory action of LH-RH on either cyclic AMP accumulation or LH-release. Flufenamic acid on its own caused LH-release, but the drug abolished the effect of LH-RH on cyclic AMP accumulation. The mechanism of this action of flufenamic acid is not understood. It is concluded that the stimulatory action of LH-RH on pituitary cyclic AMP production and LH release is not mediated by prostaglandins.

Animals↗